Fecal Microbiota Transplantations: Where Are We, Where Are We Going, and What Is the Role of the Clinical Laboratory?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical chemistry (Baltimore, Md.) Md.), 2020-04, Vol.66 (4), p.512-517
Hauptverfasser:	Ransom, Eric M, Burnham, Carey-Ann D, Jones, Lee, Kraft, Colleen S, McDonald, L Clifford, Reinink, Andrew R, Young, Vincent B
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - therapeutic use Antibiotics Clinical Laboratory Techniques - economics Clostridium Infections - microbiology Clostridium Infections - therapy Donor Selection Enforcement Expert Testimony FDA approval Fecal Microbiota Transplantation - adverse effects Fecal Microbiota Transplantation - economics Fecal Microbiota Transplantation - methods Fecal microflora Feces Fidaxomicin Health aspects Humans Infectious diseases Medical laboratories Medicine Methicillin Microbiota Microbiota (Symbiotic organisms) Multidrug resistant organisms Patients Stem cell transplantation Transplantation, Homologous Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!